| key words | Vol. No. | page | report | |
| D-dimer | Vol.86 No.07 | 717-722 | Yoshitoshi KOMAZAKI et al. | PULMONARY THROMBOEMBOLISM WITH PULMONARY TUBERCULOSIS |
| Daily health monitoring | Vol.86 No.04 | 437-444 | Yuko SUZUKI et.al. | A STUDY ON PREVENTIVE MEASURES AGAINST TUBERCULOSIS IN CARE FACILITIES FOR THE ELDERLY IN A TOKYO METROPOLITAN DISTRICT |
| Daily hospital life | Vol.77 No.09 | 609-614 | Fumio YAMAGISHI et al. | The Present Situation of Daily Life of Tuberculosis Patients Treated in Hospitals with Beds for Tuberculosis in Japan |
| Database | Vol.84 No.12 | 783-794 | Tomoshige MATSUMOTO and Tomotada IWAMOTO | ADVANCES IN MOLECULAR
EPIDEMIOLOGY OF TUBERCULOSIS OPEN THE DOOR TO THE NEXT STAGE |
| Day laborers | Vol.82 No.05 | 455-458 | Nobuaki NAKATA et al. | Significance of Tuberculosis Screening of Outpatients in Areas with High Prevalence of Tuberculosis |
| DDH | Vol.77 No.08 | 539-546 | Yutaka FUKASAWA | Microplate Hybridization Methods of Reduced Unspecific Reassociation Considering △TM -Comparison between Relative Relatedness of DNA and Key Characters for Mycobacterium szulgai |
| DDH | Vol.79 No.07 | 437-441 | Yuko KAZUMI et al. | Mycobacterium shinshuense Isolated from Cutaneous Ulcer Lesion of Right Lower Extremity in a 37-Year-Old Woman |
| DDH | Vol.85 No.05 | 461-464, | Ａｋｉｏ ＡＯＮＯ ｅｔ ａｌ． | Non-tuberculoｕｓ Mycobacterium
Strains that Show Positive Test for Identification Kits of M.
Tuberculosis Complex |
| Dead space | Vol.78 No.09 | 597-600 | Hiroyasu YOKOMISE et al. | Development of New Therapeutic Method for Empyema |
| Death | Vol.85 No.01 | 61-64 | Tuberculosis Surveillance Center | TUBERCULOSIS ANNUAL REPORT
2008 ─ Series 4. Elderly TB ─ |
| Death | Vol.85 No.08 | 683-686 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2008 ─Series 10. Treatment Outcome and TB Deaths─ |
| Death | Vol.86 No.07 | 737-741 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ―Series 4. Elderly TB― |
| Death | Vol.87 No.05 | 415-419 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ─Series 10. Treatment Outcome and TB Deaths ─ |
| Death | Vol.87 No.09 | 585-589 | Tuberculosis Surveillance Center (TSC), RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2010 ―(4) Tuberculosis in the Elderly― |
| Death rate | Vol.80 No.09 | 607-611 | Masako WADA | Anti-tuberculosis Drug-Induced Hepatitis |
| Deceased case | Vol.77 No.11 | 709-716 | Susumu HARADA et al. | A Clinical Study of Deceased Cases of Pulmonary M.avium Complex (MAC) Disease-In Contrast with Survived Cases Followed-Up for 5 Years or Longer |
| Decentralization | Vol.78 No.02 | 107-110 | Chairpersons:N. ISHIKAWA, T.AHIKO | Breakthrough for Tuberculosis Control Program in Japan |
| Decentralization | Vol.80 No.07 | 541-546 | Mitsuhiro USHIO | Amendment of Tuberculosis Prevention Law and Prospect of Tuberculosis Control Program |
| Decentralization | Vol.81 No.07 | 467-474 | Saint SALY et al. | Decentralized DOTS Shortens Delay to TB Treatment Significantly in Cambodia |
| Decline rate | Vol.75 No.09 | 533-544 | Toshio TAKATORIGE. et al. | Factors Related to the Slowdown in the Reduction of the Tuberculosis Incidence Rate in Osaka City-Structure of the High Incidence Rate of Tuberculosis in Osaka City Analyzed by Administrative-Ward Group, Five-Year Period and Age Group |
| Decrease of the local pulmonary defence mechanism | Vol.78 No.07 | 487-490 | Yoshihiro KOBASHI et al. | A case of Pulmonary Mycobacterium avium Complex Disease Complicated by Interstitial Pneumonia with Collagen Vascular Disease |
| Deep-sea | Vol.78 No.06 | 449-452 | Hidemaro ONO et al. | Four Cases of Pulmonary Tuberculosis among Deep-Sea Fishermen |
| Deep venous thrombosis | Vol.86 No.07 | 717-722 | Yoshitoshi KOMAZAKI et al. | PULMONARY THROMBOEMBOLISM WITH PULMONARY TUBERCULOSIS |
| Default | Vol.77 No.10 | 671-677 | Jumpei YAMAMURA et al. | A Study on Patients with Tuberculosis Among Foreigners Overstayed in Japan After Expiration of Visa-Activities Over Three Years |
| Default rate | Vol.78 No.09 | 581-585 | Emiko TOYOTA et al. | Usefulness of Directly Observed Therapy (DOT) during Hospitalization as DOTS in Japanese Style |
| Defaulter | Vol.75 No.11 | 675-679 | Chairpersons: M. TSUJI, T. YAMASHITA | Cooperation between Public Health Centers and Hospitals in Tuberculosis Control-How Should Clinical Nurses and Public Health Nurses Work Together? |
| Defaulter | Vol.84 No.12 | 767-781 | Fumio YAMAGISHI and Makoto TOYOTA | RESEARCH AND CONTROL OF RELAPSE TUBERCULOSIS CASES |
| Defaulting | Vol.75 No.02 | 79-88 | Jumpei YAMAMURA et al. | A Study on Tuberculosis Cases among Over-Staying Foreigners |
| Defaulting | Vol.78 No.12 | 723-732 | Yuka SASAKI et al. | A Study on Pulmonary Tuberculosis Retreatment Cases |
| Defaulting | Vol.78 No.12 | 747-750 | Shinya KONDO et al. | Infants and Children Who Developed Tuberculosis Following Contacts Investigation |
| Degree of smear positivity | Vol.87 No.08 | 541-547 | Kenji MATSUMOTO et al. | THE ASSOCIATION BETWEEN SMOKING AND SPUTUM SMEAR-POSITIVE PULMONARY TUBERCULOSIS IN OSAKA CITY |
| Delay | Vol.82 No.06 | 523-529 | Osamitsu YAGI et al. | Bone and Joint Tuberculosis Concurrent with Tuberculosi of Other Organs |
| Delay analysis | Vol.81 No.07 | 467-474 | Saint SALY et al. | Decentralized DOTS Shortens Delay to TB Treatment Significantly in Cambodia |
| Delay of case finding | Vol.85 No.02 | 139-142 | Tuberculosis Surveillance Center | TUBERCULOSIS ANNUAL REPORT 2008 |
| Delay of case finding | Vol.86 No.09 | 787-791 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ─ Series 5. Case Findings ─ |
| Delay of diagnosis | Vol.82 No.08 | 647-654 | Atsuhisa TAMURA et al. | Features of Bronchial Tuberculosis-An Analysis of 103 Cases- |
| Delay in case-finding | Vol.87 No.2 | 35-40 | Kenji MATSUMOTO et al. | EXAMINATION OF ONSET CASES IN CONTACT INVESTIGATION |
| Delayed-type hypersensitivity | Vol.76 No.05 | 407-411 | Shinya KONDO et al. | Infants 12 Month-Old or Less as a High Risk Group in Tuberculosis-Comparison of Clinical Data with Those in Children Aged One to Two Years- |
| Delayed-type hypersensitivity | Vol.78 No.01 | 1-3 | Shinya KONDO et al. | Difficulties in the Treatment of Tuberculosis in Infants |
| Delayed-type hypersensitivity | Vol.81 No.05 | 375-379 | Shinya KONDO et al. | Three Cases of Tuberculosis Children Who Demonstrated Paradoxical Worsening during Different Stage of Treatment |
| Delivery | Vol.81 No.06 | 413-418 | Tetsuya TAKASHIMA et al. | Treatment Outcome of Patients with Multidrug-Resistant Pulmonary Tuberculosis during Pregnancy |
| Delivery | Vol.77 No.11 | 703-708 | Emiko TOYOTA et al. | Management of Tuberculosis During Pregnancy and Puerperium |
| Dermatomyositis | Vol.77 No.06 | 465-470 | Masakuni FUJITA et al. | A Case of Cutaneous Tuberculosis Under Steroid & Immunosuppressant Therapy for Dermatomyositis |
| Descriptive epidemiology | Vol.79 No.09 | 579-586 | Masaki OTA et al. | An Outbreak of Tuberculosis in a Long-term Care Unit of a Mental Hospital |
| Desensitization therapy | Vol.75 No.09 | 521-526 | Yoshihiro KOBASHI et al. | Desensitization Therapy for Antituberculous Drugs |
| Desensitization therapy | Vol.75 No.12 | 699-704 | Yoshihiro KOBASHI et al. | Desensitization Therapy for Allergic Reactions of Antituberculous Drugs-Evaluation of Desensitization Therapy According to the Guideline of the Japanese Society for Tuberculosis |
| Desensitization therapy | Vol.81 No.04 | 351-355 | Hiroyuki KAMIYA et al. | A Case of Pulmonary Tuberculosis Complicated with an Orthotopic Liver Transplantation |
| Desensitization therapy | Vol.86 No.02 | 87-99 | Chairpersons: K. TSUYUGUCHI and M. WADA |
MANAGEMENT OF ADVERSE EFFECTS WITH ANTITUBERCULOSIS CHEMOTHERAPY |
| Detection rate | Vol.77 No.04 | 329-339 | Masako OHMORI et al. | Discussing the Current Situation of Tuberculosis Case-Finding by Mass Miniature Radiography in Japan |
| Detection rate of TB cases | Vol.85 No.11 | 799-803 | Tadao SHIMAO | MASS HEALTH EXAMINATION FOR TUBERCULOSIS |
| Detention | Vol.80 No.01 | 31-45 | Chairpersons:H. NAGAI. T. INAGAKI | Tuberculosis and Human Rights |
| Detention | Vol.86 No.04 | 459-471 | Kunihiko ITO | LEGAL ENFORCEMENT FOR NON-ADHERENT TUBERCULOSIS PATIENTS |
| Development | Vol.77 No.11 | 735-740 | Sang Jae Kim | Current Problems of Drug-Resistant Tuberculosis and Its Control |
| Development mechanism | Vol.82 No.12 | 903-918 | Kenji HIBIYA et al. | The Pathogenesis and the
Development Mechanism of Mycobacterium avium Complex Infection |
| Development of active tuberculosis | Vol.85 No.07 | 595-599 | Nobuyuki HARADA | Interpretation of QFT Results in Several Contact Investigations |
| Diabates | Vol.85 No.05 | 495-498 | Tuberculosis Surveillance Center,RIT,JATA |
Tuberculosis Annual Report 2008 -Series7. Condition of TB(2)- |
| Diabetes | Vol.79 No.01 | 25-32 | Ryuzo KAWAMORI | Diabetes and Tuberculosis-Bad Companions- |
| Diabetes | Vol.86 No.11 | 883-887 | Tuberculosis Surveillance Center | TUBERCULOSIS ANNUAL REPORT 2009 ─Series7. Condition of TB(2)─ |
| Diabetes mellitus | Vol.75 No.08 | 505-509 | Fumio YAMAGISHI et al. | Management of Pulmonary Tuberculosis Patients Complicated with Diabetes Mellitus before Diagnosis as Pulmonary Tuberculosis and Feasibility of Chemoprophylaxis |
| Diabetes Mellitus | Vol.75 No.11 | 665-673 | Masako WADA | The Effectiveness of Pyrazinamide-Containing Six-Month Short Course Chemotherapy |
| Diabetes mellitus | Vol.76 No.02 | 77-81 | Fumio YAMAGISHI | Prevention of Development of Pulmonary Tuberculosis in Compromised Host |
| Diabetes mellitus | Vol.76 No.06 | 447-454 | Yasuhiro YAMAGUCHI et al. | A Study on the Clinical Features of Pulmonary Tuberculosis in Elderly Patients |
| Diabetes mellitus | Vol.76 No.09 | 619-624 | Mouka TAMURA et al. | A Study on Relation between Active Pulmonary Tuberculosis and Underlying Diseases |
| Diabetes mellitus | Vol.77 No.05 | 409-413 | Katsuhiko TSUKAGUCHI et al. | Longitudinal Assessment of IFN-γProduction in Patients with Pulmonary Tuberculosis Complicated with Diabetes Mellitus |
| Diabetes mellitus | Vol.77 No.12 | 799-804 | Fumio YAMAGISHI | Medical Risk Factors of Tuberculosis and Countermeasures |
| Diabetes mellitus | Vol.78 No.10 | 661-667 | Fumio YAMAGISHI | Measures for Tuberculosis in Compromised Hosts-Mainly on Chemoprophylaxis- |
| Diabetes mellitus | Vol.78 No.11 | 717-722 | Chairpersons:F.YAMAGISHI and K.SHIMOKATA | Tuberculosis in Compromised Hosts |
| Diabetes mellitus | Vol.79 No.01 | 1-6 | Yoshihiro KOBASHI et al. | Clinical Analysis of Pulmonary Tuberculosis Detected during Follow-up of Other Underlying Diseases |
| Diabetes mellitus | Vol.81 No.10 | 631-638 | Fumio YAMAGISHI | The Clinical Features for Tuberculosis in Compromised Hosts |
| Diabetes mellitus | Vol.87 No.06 | 453-459 | Satoko SUNAGAWA et al. | CLINICAL FEATURES OF DIABETIC PATIENTS WITH PULMONARY TUBERCULOSIS ADMITTED TO A UNIVERSITYHOSPITAL |
| Diabetes mellitus | Vol.87 No.12 | 783-787 | Tuberculosis Surveillance | TUBERCULOSIS ANNUAL REPORT 2010 ─ (7) Tuberculosis Characteristics upon Diagnosis-2 ─ |
| Diagnosis | Vol.77 No.05 | 427-431 | Tatsuyoshi IKEUE et al. | Pulmonary Infection Caused by Mycobacterium szulgai: A Case Report |
| Diagnosis | Vol.79 No.11 | 645-653 | Toshihiko KURAOKA | Diagnostic Key-point of the Pulmonary Tuberculosis |
| Diagnosis | Vol.79 No.04 | 289-295 | Keisuke AOE et al. | Diagnosis and Treatment of Tuberculous Pleurisy-With Special Reference to the Significance of Measurement of Pleural Fluid Cytokines- |
| Diagnosis | Vol.79 No.05 | 349-354 | Tetsuya UEDA et al. | Tuberculous Lymphadenitis:A Clinical Study of 23 Cases |
| Diagnosis | Vol.80 No.08 | 581-585 | Peter ANDERSEN et al. | Replacing the Tuberculin Skin Test with a Specific Blood Test |
| Diagnosis | Vol.81 No.06 | 401-405 | Kunihiko ITO et al. | The Role of Simultaneous Combination Culture with Solid and Liquid Media for Diagnosis of Pulmonary Tuberculosis |
| Diagnosis | Vol.81 No.08 | 511-518 | Kunihiko ITO et al. | Number of Sputum Cultures by MGIT System Needed to Diagnose Pulmonary Tuberculosis |
| Diagnosis | Vol.86 No.04 | 431-436 | Satoko YONESHIMA et.al. | CLINICAL REVIEW OF 8 PATIENTS WITH TUBERCULOUS PERITONITIS |
| Diagnosis of tuberculosis infection | Vol.77 No.10 | 659-664 | Eriko SHIGETOH et al. | Repeated Tuberculin Skin Tests in Nurse Students-Observation for 3 Years |
| Diagnosis of tuberculosis infection | Vol.81 No.11 | 681-686 | Nobuyuki HARADA | Characteristics of a Diagnostic Method of Tuberculosis Infection Based on Whole Blood Interferon-γ Assay |
| Diagnostic criteria | Vol.79 No.07 | 431-435 | Tetsuro INOUE et al. | Clinical Ebaluation on Isolation of Mycobacterium kansasii in Our Hospital |
| Diagnostic criteria | Vol.85 No.02 | 87-93 | Atsuyuki KURASHIMA | JAPANESE NEW GUIDELINES FOR
NONTUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE |
| Diagnostic criteria | Vol.88 No.03 | 283-289 | Yasuharu NAKAHARA et al. | PULMONARY LESIONS IN WHICH NONTUBERCULOUS MYCOBACTERIA WERE DETECTED BY PERCUTANEOUS ASPIRATION |
| Diagnostic standard | Vol.77 No.12 | 815-821 | Atsuyuki KURASHIMA | Diagnosis and Treatment of Pulmonary Nontuberculous Mycobacteriosis |
| Diagnostics | Vol.79 No.12 | 725-735 | Nobuyuki HARADA et al. | Basic Characteristics of a Novel Diagnostic Method (QuantiFERON® TB-2G) of Latent Tuberculosis Infection with a Use of Mycobacterium tuberculsis-Specific Antigens, ESAT-6 and CFP-10 |
| Diagnostics for tuberculosis infection | Vol.84 No.04 | 173-186 | Kazue HIGUCHI et al. | Research Agenda of Interferon-Gamma Release Assays |
| Dialysis | Vol.78 No.11 | 717-722 | Chairpersons:F.YAMAGISHI and K.SHIMOKATA | Tuberculosis in Compromised Hosts |
| Dialysis | Vol.86 No.11 | 857-862 | Chihiro FUKUSHIMA et al. | PROBLEMS OF TUBERCULOSIS PATIENTS UNDER DIALYSIS IN TAMA AREA, TOKYO |
| Differential diagnosis | Vol.84 No.08 | 585-590 | Hiroshi TANAKA et al. | Differential Diagnosis of Pulmonary Mycobacterial Infection; Radiological Findings Mimicking Tuberculous or Nontuberculous Mycobacterial Pneumonia |
| Difficulties in treatment adherence | Vol.88 No.04 | 429-437 | Reiko SAITO et al. | ON-THE-STREET DOTS FOR A HOMELESS TUBERCULOSIS PATIENT ─ Case Report of a Patient Who Had Diffi culties with TB Treatment Adherence ─ |
| Diffuse large B-cell lymphoma (DLBCL) | Vol.87 No.10 | 663-667 | Shojiro MINOMO et al. | ENLARGEMENT OF INTRATHORACIC DIFFUSE LARGE B-CELL LYMPHOMA DURING TREATMENT OF PULMONARY TUBERCULOSIS: A CASE REPORT |
| Diplopia | Vol.87 No.07 | 501-505 | Kazuyoshi NAKAMURA et al. | A CASE OF PULMONARY TUBERCULOSIS ASSOCIATED WITH ORBITAL MYOSITIS |
| Direct BCG vaccination | Vol.80 No.08 | 565-569 | Shinya KONDO et al. | Clinical Characteristics in Non-Symptomatic Infants with Tuberculosis Whose Diagnostic Clue Was Regular Tuberculin Skin Test Prior to BCG Vaccination |
| Direct smear | Vol.81 No.09 | 573-576 | Kunihiko ITO | Comparison between Direct Smear by Ziehl-Neelsen and Concentrated Smear by Fluorochrome Stain |
| Direct smear examination | Vol.80 No.02 | 95-111 | Chairpersons:S. ICHIYAMA and K. SUZUKI | Clinical Application of Testing Methods on Acid-Fast Bacteria |
| Directly observed chemotherapy | Vol.82 No.10 | 771-781 | Masako WADA | Anti-Tuberculosis Chemotherapy |
| Directly observed treatment | Vol.78 No.12 | 723-732 | Yuka SASAKI et al. | A Study on Pulmonary Tuberculosis Retreatment Cases |
| Directly observed treatment | Vol.81 No.05 | 363-369 | Masako WADA et al. | Twice-Weekly Intermittent Chemotherapy during the Maintenance Phase of the Short-Course Treatment for New Patients with Pulmonary Tuberculosis |
| Directly observed treatment | Vol.86 No.04 | 445-451 | Eriko SHIGETO | TREATMENT AND ISOLATION OF NON-ADHERENT AND/OR INFECTIOUS TUBERCULOSIS PATIENTS UNDER THE INFECTIOUS DISEASES CONTROL LAW |
| Directly Observed Treatment Short-course(DOTS) | Vol.85 No.03 | 158-162, | Hamood Yahya MAHYIUOB AL-HONAHI et al. | A Trial to Mobilize NGO Health Volunteers to Improve Tuberculosis Patient Care in SANA'A City, YEMEN |
| Disappearance of drug resistance | Vol.76 No.04 | 379-383 | Eriko SHIGETO et al. | A Case of Drug-Resistant Pulmonary Tuberculosis Treated Successfully Following Disappearance of Rifampicin Resistance after 17 Years' Chemotherapy |
| Disaster | Vol.86 No.12 | 933-943 | Chairperson: Toru MORI | The 86th Annual Meeting Emergency Symposium - THE EAST JAPAN EARTHQUAKE AND TSUNAMI DISASTER AND TUBERCULOSIS |
| Discharge criteria | Vol.82 No.01 | 11-17 | Michihiro FUJINO et al. | New Criteria for Discharge from Ward in Patients with Pulmonary Tuberculosis Using Mycobacteria Growth Indicator Tube |
| Discharge criteria | Vol.85 No.03 | 151-154, | Fumie MISHIMA et al. | THE CHANGES OF HOSPITALIZATION
IN OUR TUBERCULOUS WARD AFTER NEW DISCHARGE CRITERIA |
| Discharge Isolation | Vol.81 No.12 | 721-730 | Kunihiko ITO et al. | Criteria of Hospitalization and Discharge for Tuberculosis in the Western Developed Countries and Comparison with That of Japan |
| Discharge-criteria | Vol.80 No.10 | 631-636 | Ayako MIKAMI et al. | The Impact of the Change in Criteria for Hospital Discharge of Patients with Tuberculosis on the Duration of Hospitalization |
| Discharging criteria | Vol.79 No.06 | 375-380 | Naoshi YANAGISAWA et al. | Current Status of the Criteria for Discharging Patients with Pulmonary Tuberculosis-Results of Questionnaire Survey on the Criteria for Discharging Patients from Tuberculosis Wards of the Hospitals in Kanto Area- |
| Discontinuation of standard chemotherapy | Vol.76 No.05 | 427-436 | CSUCTNS | Clinical Study on the Cases in Which INH or RFP was Discontinued during Treatment for Pulmonary Tuberculosis |
| Disease | Vol.76 No.02 | 83-91 | Jerrold J. ELLNER | The Human Immune Response to Mycobacterium tuberculosis Infection and Disease |
| Disease control | Vol.79 No.09 | 587-604 | Toru MORI | Reform of Japan's NTP and its Technical Perspectives |
| Disease status | Vol.79 No.04 | 297-300 | Shuichi YANO et al. | The Clinical Features of Ultra-Old Tuberculosis Patients in Our Hospital |
| Disease status | Vol.80 No.09 | 591-594 | Shuichi YANO et al. | Improvement on Chest X-ray Findings after Two Months of Antituberculous Treatment |
| Disease susceptibility | Vol.85 No.03 | 163-177, | Naoto Keicho and Etsuro YAMAGUCHI | Cenetic Predispositon to Tuberculosis in Asia -Present Approach and Future Directions- |
| Disease susceptibility genes | Vol.87 No.05 | 433-448 | Chairpersons: Atsuyuki KURASHIMA and Kenji OGAWA | ─The 86th Annual Meeting Symposium─ FOREFRONT OF THE CLINIC AND RESEARCH OF PULMONARY MAC DISEASE |
| Disseminated BCG infection | Vol.84 No.08 | 597-603 | Shigehiro ENKAI et al. | A Case of Disseminated BCG Infection Found during Treatment of an Infant with Crohn's Disease |
| Disseminated disease | Vol.84 No.08 | 569-575 | Shinobu AKAGAWA | Chest X-ray Image Findings of Mycobacterium avium complex(MAC) Lung Disease |
| Disseminated intravascular coagulation | Vol.87 No.12 | 771-776 | Sachiko SHIRAISHI et al. | A CASE OF MILIARY TUBERCULOSIS COMPLICATED BY DISSEMINATED INTRAVASCULAR COAGULATION AND ACUTE RESPIRATORY DISTRESS SYNDROME SUCCESSFULLY TREATED WITH RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN |
| Disseminated Mycobacterium kansasii infection | Vol.80 No.04 | 359-364 | Yutaro SUZUKI et al. | A Rare Case of Disseminated Mycobacterium kansasii Infection |
| Disseminated tuberculosis | Vol.81 No.11 | 667-671 | Junichi TSUYUSAKI et al. | A Case of Disseminated Tuberculosis Complicated with Tuberculous Meningitis while Investigating an Abdominal Lymphadenopathy |
| Dissemination | Vol.78 No.12 | 747-750 | Shinya KONDO et al. | Infants and Children Who Developed Tuberculosis Following Contacts Investigation |
| Dissemination | Vol.82 No.12 | 903-918 | Kenji HIBIYA et al. | The Pathogenesis and the
Development Mechanism of Mycobacterium avium Complex Infection |
| Distribution | Vol.87 No.05 | 397-402 | Atsuyuki KURASHIMA et al. | DISTRIBUTION OF PULMONARY MYCOBACTERIUM AVIUM COMPLEX (MAC) DISEASE CAVITIES AND THEIR COURSE UNDER CHEMOTHERAPY |
| District | Vol.86 No.07 | 729-735 | Masako OHMORI et al. | THE USE OF NATIONWIDE TUBERCULOSIS SURVEILLANCE SYSTEM DATA TO DETERMINE GEOGRAPHICAL DIFFERENCES IN DRUG RESISTANCE ― Consideration of the Representativeness of the Drug Resistance Rate in Japan ― |
| DNA | Vol.75 No.12 | 705-709 | Yoshiyuki ABE et al. | A Case of Pulmonary Tuberculosis Diagnosed by DNA Amplification Methods from Transbronchial Lung Biopsy Materials |
| DNA | Vol.85 No.06 | 509-514, | Kunio TSUJIMURA and Yukio KOIDE |
T Cell-mediated Immune Responses and the Recognition of Tuberculosis Antigens |
| DNA fingerprinting | Vol.81 No.04 | 321-328 | Hiromi ANO et al. | Molecular Epidemiology of Tuberculosis by the Use of IS6110 Restriction Fragment Length Polymorphism:A Study from 2001 to 2003 |
| DNA microarray | Vol.81 No.12 | 709-713 | Hiromi ANO et al. | Resistance-Conferring Mutations of Mycobacterium tuberculosis Strains with Low Level Resistance to Isoniazid |
| Doctor's delay | Vol.75 No.09 | 527-532 | Yuka SASAKI et al. | A Study of Patient's and Doctor's Delay in Patients with Pulmonary Tuberculosis Discovered by Visiting Doctors with Symptoms in Particular on Doctor's Delay |
| Doctor's delay | Vol.75 No.10 | 569-573 | Yuka SASAKI et al. | A Clinical Study in the Collagen Disease Patients Developed Pulmonary Tuberculosis during Corticosteroid Administration |
| Doctor's delay | Vol.77 No.09 | 621-625 | Yuka SASAKI | A Study of Case Findings In Pulmonary Tuberculosis Patients |
| Doctor's delay | Vol.88 No.01 | 9-13 | Atsuhisa TAMURA et al. | DOCTOR'S DELAY IN ENDOBRONCHIAL TUBERCULOSIS |
| Dormant-type tubercle bacilli | Vol.85 No.11 | 809-813 | Haruaki TOMIOKA | PROSPECTS FOR THE DEVELOPMENT OF NEW ANTITUBERCULOUS DRUGS PUTTING OUR HOPES ON NEW DRUG TARGETS |
| Dormitory housing for construction worker | Vol.84 No.11 | 701-707 | Hidetoshi IGARI | Tuberculosis among Construction Workers from Dormitory Housings in Chiba City |
| DOT | Vol.75 No.10 | 611-617 | Chairpersons:T. TAKETORIGE, T. AHIKO | Tuberculosis Control of Urban Areas in Japan |
| DOT | Vol.76 No.12 | 749-753 | Emiko TOYOTA | DOTS in Japan-Tokyo Area |
| DOT | Vol.76 No.12 | 755-757 | Yohichi TATSUMI | DOTS in Osaka City |
| DOT | Vol.77 No.01 | 29-35 | Paula I. FUJIWARA | A Decade of Successful Tuberculosis Control in New York City-The Role of DOT vs DOTS |
| DOT | Vol.80 No.04 | 381-388 | Keiichi HOSHINO et al. | Usefulness of Support during Treatment by Alignment with Health Centers and DOT during Hospitalization |
| DOT during hospitalization | Vol.78 No.09 | 581-585 | Emiko TOYOTA et al. | Usefulness of Directly Observed Therapy (DOT) during Hospitalization as DOTS in Japanese Style |
| DOT for outpatients | Vol.82 No.02 | 125-141 | Chairpersons:E.TOYOTA and K.OGAWA | The New Criteria for Discharge from Tuberculosis Ward-Practical Use and Problem |
| DOT(directly observed therapy) | Vol.79 No.01 | 17-24 | Yuki TADA et al. | Tuberculosis Control in Kawasaki City-Promoting the DOT Program |
| DOTS | Vol.76 No.11 | 707-713 | Chairpersons:K. KOKUBU, K. INUZUKA | Medical Treatment Support to Tuberculous Patients-From the Standpoint of Community Support- |
| DOTS | Vol.76 No.12 | 749-753 | Emiko TOYOTA | DOTS in Japan-Tokyo Area |
| DOTS | Vol.76 No.12 | 755-757 | Yohichi TATSUMI | DOTS in Osaka City |
| DOTS | Vol.77 No.01 | 29-35 | Paula I. FUJIWARA | A Decade of Successful Tuberculosis Control in New York City-The Role of DOT vs DOTS |
| DOTS | Vol.77 No.09 | 597-603 | Tomoko KIMURA et al. | Tuberculosis Control of Construction Workers Living in Hanba |
| DOTS | Vol.78 No.09 | 581-585 | Emiko TOYOTA et al. | Usefulness of Directly Observed Therapy (DOT) during Hospitalization as DOTS in Japanese Style |
| DOTS | Vol.78 No.02 | 107-110 | Chairpersons:N. ISHIKAWA, T.AHIKO | Breakthrough for Tuberculosis Control Program in Japan |
| DOTS | Vol.79 No.02 | 59-61 | Chairpersons:Hideo OGATA and Takeko YAMASHITA | The Results of DOTS Strategy |
| DOTS | Vol.79 No.12 | 743-746 | Chairpersons:A. NASU, N. KOBAYASHI | Nursing on Tuberculosis Patients-Quality Nursing to Support Patient's Compliance to Treatment |
| DOTS | Vol.79 No.09 | 587-604 | Toru MORI | Reform of Japan's NTP and its Technical Perspectives |
| DOTS | Vol.80 No.02 | 89-94 | Nobukatsu ISHIKAWA | How to Combat against Global Tuberculosis Burden-Experiences and Perspectives for Japan's International Cooperation |
| DOTS | Vol.80 No.08 | 577-580 | Lee B. REICHMAN | Tuberculosis:The Global Timebomb |
| DOTS | Vol.80 No.10 | 631-636 | Ayako MIKAMI et al. | The Impact of the Change in Criteria for Hospital Discharge of Patients with Tuberculosis on the Duration of Hospitalization |
| DOTS | Vol.80 No.11 | 719-729 | Chairperson:N. KOBAYASHI | Needs for Assessment of Treatment Outcome by Cohort Analysis |
| DOTS | Vol.81 No.07 | 467-474 | Saint SALY et al. | Decentralized DOTS Shortens Delay to TB Treatment Significantly in Cambodia |
| DOTS | Vol.81 No.10 | 591-602 | Hitoshi HOSHINO et al. | Evaluation of Effect of Community DOTS on Treatment Outcomes by TB Surveillance Data |
| DOTS | Vol.81 No.12 | 715-720 | Eriko MORINO et al. | Effects of New Discharge Criteria Incorporating DOTS on Treatment Outcome of Patients with Smear-Positive Tuberculosis |
| DOTS | Vol.82 No.01 | 19-25 | Toshio TAKATORIGE et al. | Tuberculosis and Its Control Measures for Homeless People: Implementation of Chest X-ray Examination for Three Successive Years |
| DOTS | Vol.82 No.01 | 39-51 | Chairpersons:K.TAKEUCHI and K. KOKUBU | Let's DOTS-Embodying the Desire of Nursing to Heal in DOTS |
| DOTS | Vol.82 No.02 | 119-123 | Tadayuki AHIKO | Outcomes and Problems of DOTS Strategy in Japan |
| DOTS | Vol.82 No.12 | 941-957 | Chairpersons: T.AHIKO and N.KOBAYASHI | Effective Measures for Promoting
the New Tuberculosis Control Program of Japan |
| DOTS | Vol.84 No.04 | 173-186 | Tomoya NARITA and Noriko KOBAYASHI |
Development and Perspectives of Community DOTS |
| DOTS | Vol.84 No.11 | 701-707 | Hidetoshi IGARI | Tuberculosis among Construction Workers from Dormitory Housings in Chiba City |
| DOTS | Vol.85 No.02 | 69-78 | Mari YAMADA et al. | USE OF A RISK ASSESSMENT
INVENTORY IN IMPLEMENTATION OF THE COMMUNITY DOTS IN SHINJUKU, JAPAN |
| DOTS | Vol.78 No.02 | 95-100 | Toru MORI | Tuberculosis and Society |
| DOTS | Vol.85 No.12 | 881-894 | Chairpersons: M
TOYOTA, Y SASAKI |
The 85th Annual Meeting Symposium - THE ISSUE OF TUBERCULOSIS IN THE ELDERLY IN JAPAN |
| DOTS | Vol.86 No.10 | 821-827 | Naoki NAKATSUBO et al. | THE IMPLEMENTATION STATUS OF COMMUNITY DIRECTLY OBSERVED THERAPY SHORT-COURSE (DOTS) PRACTICE IN MEDICAL FACILITIES DESIGNATED FOR TUBERCULOSIS TREATMENT IN THE TAMA AREA |
| DOTS | Vol.86 No.12 | 971-981 | Chairpersons: 1 Tadayuki AHIKO and 2 Tomoyo NARITA | The 86th Annual Meeting Mini-Symposium - COOPERATION OF RELEVANT ORGANIZATIONS FOR TUBERCULOSIS CONTROL |
| DOTS | Vol.87 No.11 | 737-741 | Kenji MATSUMOTO et al. | EVALUATION OF THE EFFECT OF DOTS ON TREATMENT OUTCOMES IN PATIENTS WITH SMEAR-POSITIVE PULMONARY TUBERCULOSIS IN OSAKA CITY |
| DOTS | Vol.87 No.12 | 795-808 | Chairpersons: Akira FUJITA and Tomoyo NARITA | ─The 87th Annual Meeting Symposium─PATIENT-CENTERED MEDICINE FOR TUBERCULOSIS MEDICAL SERVICES |
| DOTS conference | Vol.84 No.04 | 173-186 | Tomoya NARITA and Noriko KOBAYASHI |
Development and Perspectives of Community DOTS |
| DOTS conference | Vol.87 No.02 | 71-81 | Chairpersons: Yoko NAGATA and Keiko KUDO |
The 86th Annual Meeting Mini-Symposium ROLE OF NURSING IN TUBERCULOSIS CARE |
| DOTS strategy | Vol.78 No.01 | 37-44 | Shigeru OMI | Tuberculosis Control Strategy in Asia for the 21st Century-Tuberculosis Control in the Western Pacific Region of World Health Organization |
| Double-strain infection | Vol.79 No.06 | 387-390 | Kunihiko ITO et al. | Multi-Drug Resistant Lung Tuberculosis Due to Double Infection of MDR Strain |
| DRG/PPS | Vol.85 No.03 | 145-150 | Katsuyuki TOBISE et al. | A DRG/PPS SIMULATION IN THE MEDICAL CARE OF TUBERCULOSIS |
| Droplet nuclei infection | Vol.79 No.09 | 509-518 | Masakazu AOKI | Transmission of Tuberculosis(I) |
| Drop-out | Vol.79 No.08 | 461-467 | Kunihiko ITO et al. | Drug Resistance in Recurrent Cases of Tuberculosis |
| Drop-out | Vol.86 No.04 | 445-451 | Eriko SHIGETO | TREATMENT AND ISOLATION OF NON-ADHERENT AND/OR INFECTIOUS TUBERCULOSIS PATIENTS UNDER THE INFECTIOUS DISEASES CONTROL LAW |
| Drug administration support | Vol.80 No.11 | 719-729 | Chairperson:N. KOBAYASHI | Needs for Assessment of Treatment Outcome by Cohort Analysis |
| Drug delivery | Vol.81 No.12 | 753-774 | Chairpersons:H. TOMIOKA and K. NAMBA | Development of Antituberculous Drugs:Current Status and Future Prospects |
| Drug-induced auto-immune thrombocytopenia | Vol.87 No.04 | 345-349 | Namiko HASHIGUCHI et.al. | ACASE OF PULMONARY TUBERCULOSIS COMPLICATED WITH SEVERE THROMBOCYTOPENIA DURING TREATMENT |
| Drug induced hepatitis | Vol.76 No.01 | 33-43 | Masako WADA | Effectiveness and Problems of PZA-Containing 6-month Regimen for the Treatment of New Pulmonary Tuberculosis Patients |
| Drug-induced hepatitis | Vol.88 No.03 | 297-300 | Naoki MIYAZAWA et al. | COMPARISON OF DRUG-INDUCED HEPATITIS OCCURRING IN ELDERLY AND YOUNGER PATIENTS DURING ANTI-TUBERCULOSIS TREATMENT WITH A REGIMEN INCLUDING PYRAZINAMIDE |
| Drug-induced hypersensitivity syndrome | Vol.87 No.12 | 777-782 | Shinichi IWAMOTO et al. | A CASE OF ATYPICAL DRUG-INDUCED HYPERSENSITIVITY SYNDROME CAUSED BY ISONIAZID |
| Drug induced liver dysfunction | Vol.81 No.07 | 457-465 | Akira SAITO et al. | Tuberculosis Complicated with Liver Cirrhosis |
| Drug induced liver dysfunction | Vol.82 No.09 | 705-709 | Yoshitaka HARADA et al. | A Case of Fatal Liver Failure Due to Anti-Tuberculous Therapy |
| Drug interaction | Vol.81 No.04 | 351-355 | Hiroyuki KAMIYA et al. | A Case of Pulmonary Tuberculosis Complicated with an Orthotopic Liver Transplantation |
| Drug interaction | Vol.82 No.08 | 641-646 | Hisashi TAKI et al. | Clinical Analysis of Drug Interaction between Rifampicin and Clarithromycin Which Are Used for Treating Pulmonary Mycobacterium avium Complex Infection |
| Drug interactions | Vol.82 No.07 | 563-567 | Yoshinori MATSUI et al. | Examination of Administrative Dosage of Cyclosporine during the Anti-Tuberculosis Chemotherapy Including Rifampicin |
| Drug lymphocyte stimulation test | Vol.78 No.05 | 401-406 | Hidekazu MATSUSHIMA et al. | A Case of Isoniazid Sodium Methanesulfonate Induced Interstitial Pneumonia |
| Drug lymphocyte stimulation test | Vol.86 No.04 | 473-476 | Chihiro NISHIO et. al. | PNEUMONITIS INDUCED BY RIFAMPICIN |
| Drug lymphocyte stimulation test | Vol.87 No.12 | 777-782 | Shinichi IWAMOTO et al. | A CASE OF ATYPICAL DRUG-INDUCED HYPERSENSITIVITY SYNDROME CAUSED BY ISONIAZID |
| Drug resistance | Vol.76 No.12 | 717-721 | Takenori YAGI et al. | Clinical Analysis of Multidrug-Resistant Tuberculosis |
| Drug resistance | Vol.77 No.11 | 735-740 | Sang Jae Kim | Current Problems of Drug-Resistant Tuberculosis and Its Control |
| Drug resistance | Vol.78 No.10 | 653-659 | Tadashi ISHIDA | Role of Oral Fluoroquinolones in Patients with Respiratory Diseases |
| Drug resistance | Vol.78 No.12 | 739-746 | Hiromi ANO et al. | Fluctuation in the Ratio between Drug-Resistant and -Susceptible M.tuberculosis Bacilli Which Were Isolated from Patients with Prolonged Anti-Tuberculosis Treatment |
| Drug resistance | Vol.79 No.08 | 461-467 | Kunihiko ITO et al. | Drug Resistance in Recurrent Cases of Tuberculosis |
| Drug resistance | Vol.79 No.11 | 631-635 | Kunihiko ITO et al. | Are Tuberculosis Advisory Committees Well-Functioning? |
| Drug resistance | Vol.81 No.01 | 1-5 | Yoshiaki TAO et al. | Clinical Analysis of Cases with Multidrug-Resistant Tuberculosis-Inpatients at National Hospitals in Kyushu between 1998 and 2003- |
| Drug resistance | Vol.82 No.02 | 95-101 | Takashi YOSHIYAMA et al. | Treatment Results of Rifampicin (RFP) Resistant Isoniazid (INH) Susceptible Tuberculosis, a Hospital Based Study |
| Drug resistance | Vol.84 No.12 | 767-781 | Fumio YAMAGISHI and Makoto TOYOTA | RESEARCH AND CONTROL OF RELAPSE TUBERCULOSIS CASES |
| Drug resistance | Vol.86 No.07 | 703-708 | Shuichi TAKIKAWA et.al. | CLINICAL FEATURES OF FOREIGN-BORN TUBERCULOSIS PATIENTS TREATED AT OUR HOSPITAL |
| Drug resistance | Vol.87 No.04 | 357-365 | Masako OHMORI et al. | THE BACKGROUND OF DRUG-RESISTANT TUBERCULOSIS PATIENTS ON THE BASIS OF THE ANNUAL REPORT DATABASE FOR 2007-2009 IN JAPAN |
| Drug resistance | Vol.87 No.09 | 565-575 | Toru MORI et al. | CURRENT STATUS OF MULTIDRUG-RESISTANT TUBERCULOSIS IN JAPAN: A LITERATURE REVIEW AND META-ANALYSIS |
| Drug resistance test | Vol.86 No.11 | 883-887 | Tuberculosis Surveillance Center | TUBERCULOSIS ANNUAL REPORT 2009 ─Series7. Condition of TB(2)─ |
| Drug resistant gene | Vol.75 No.12 | 725-728 | Yoshinori HASEGAWA et al. | Molecular Genetic Approaches to Mycobacterium tuberculosis |
| Drug resistant gene | Vol.85 No.02 | 125-137 | Kazunari TSUYUGUCHI and Hideaki OHNO | CURRENT STATUS OF MULTI-DRUG RESISTANT TUBERCULOSIS IN JAPAN |
| Drug resistant tuberculosis | Vol.76 No.06 | 461-471 | Tuberculosis Research Committee(Ryoken) | A Study on Resistance of Mycobacterium tuberculosis to Four First-Line Anti-Tuberculosis Drugs in Japan:Comparison of Results in the Local Facilities and in the Reference Laboratory, in 1997 |
| Drug resistant tuberculosis | Vol.76 No.11 | 699-706 | Chiyoji ABE | Anti-Tuberculosis Drug Resistance in Japan and in the World |
| Drug resistant tuberculosis | Vol.88 No.05 | 485-489 | Ayaka TAKAGI et al. | PRIMARY NASOPHARYNGEAL TUBERCULOSIS |
| Drug screening | Vol.77 No.08 | 573-584 | Haruaki TOMIOKA | Prospects for Development of New Antituberculous Drugs |
| Drug sensitivity | Vol.78 No.09 | 587-590 | Kunihiko ITO et al. | Activity of Cephems and Carbapenems against Clinically Isolated Mycobacterium abscessus |
| Drug sensitivity test | Vol.76 No.12 | 723-728 | Eriko SHIGETOH et al. | Treatment Outcomes of Multidrug-Resistant Tuberculosis-Comparison between Success and Failure Cases- |
| Drug sensitivity test | Vol.79 No.11 | 631-635 | Kunihiko ITO et al. | Are Tuberculosis Advisory Committees Well-Functioning? |
| Drug sensitivity test | Vol.79 No.09 | 561-567 | Kunihiko ITO et al. | Miss-managements in Treatment Failure of Pulmonary Tuberculosis |
| Drug sensitivity test | Vol.85 No.10 | 737-742 | Masao OKUMURA et al. | CLINICAL ANALYSIS OF EXTENSIVELY-DRUG RESISTANT TUBERCULOSIS (XDR-TB) IN OUR HOSPITAL |
| Drug susceptibility | Vol.77 No.12 | 805-813 | Yutsuki NAKAJIMA | Treatment for Multidrug-Resistant Tuberculosis in Japan |
| Drug susceptibility test | Vol.82 No.07 | 577-581 | Kazuhiko KOYAMA et al. | A Case of Pulmonary Multi-Drug Resistant Tuberculosis with Left Destroyed Lung, Treated with Pneumonectomy |
| Drug susceptibility test | Vol.82 No.10 | 759-763 | Katsunori SUZUKI et al. | A Case of Pulmonary Infection with Mycobacterium chelonae in Healthy Breast-Feeding Woman |
| Drug susceptibility test | Vol.86 No.07 | 729-735 | Masako OHMORI et al. | THE USE OF NATIONWIDE TUBERCULOSIS SURVEILLANCE SYSTEM DATA TO DETERMINE GEOGRAPHICAL DIFFERENCES IN DRUG RESISTANCE ― Consideration of the Representativeness of the Drug Resistance Rate in Japan ― |
| Drug susceptibility testing | Vol.76 No.06 | 461-471 | Tuberculosis Research Committee(Ryoken) | A Study on Resistance of Mycobacterium tuberculosis to Four First-Line Anti-Tuberculosis Drugs in Japan:Comparison of Results in the Local Facilities and in the Reference Laboratory, in 1997 |
| Drug susceptibility testing | Vol.76 No.10 | 657-662 | Chiyoji ABE. et al. | Evaluation of the BACTEC MGIT 960 System for Drug Susceptibility Testing of Mycobacterium tuberculosis Isolates Compared with the Proportion Method on Solid Media |
| Drug susceptibility testing | Vol.76 No.11 | 699-706 | Chiyoji ABE | Anti-Tuberculosis Drug Resistance in Japan and in the World |
| Drug susceptibility testing | Vol.79 No.11 | 625-630 | Motohisa TOMITA et al. | A Study on Inoculum Density and Reproducibility of Drug Susceptibility Testing by BACTEC MGIT960 |
| Drug susceptibility testing | Vol.80 No.04 | 349-358 | Satoshi MITARAI, Committee for Mycobacterial Examinations, Japanese Society for Tuberculosis | The External Quality Assessment for Mycobacterium tuberculosis Drug Susceptibility Testing by Proficiency Testing Panel to the Commercial Laboratories |
| Drug susceptibility testing | Vol.81 No.08 | 501-509 | Satoshi MITARAI, The Committee for Mycobacterial Examinations, The Japanese Society for Tuberculosis | External Quality Assessment of Drug Susceptibility Testing for Mycobacterium tuberculosis |
| Drug susceptibility testing | Vol.82 No.03 | 155-164 | RYOKEN | Anti-Tuberculosis Drug Resistance Survey in Japan, 2002:External Quality Assessment of Results:Tuberculosis Research Committee (RYOKEN) |
| Drug susceptibility testing | Vol.87 No.2 | 41-45 | Shiomi YOSHIDA et al. | MOLECULAR EPIDEMIOLOGY OF RIFAMPICIN MONO-RESISTANT MYCOBACTERIUM TUBERCULOSIS |
| Drug targets | Vol.77 No.08 | 573-584 | Haruaki TOMIOKA | Prospects for Development of New Antituberculous Drugs |
| Drug targets | Vol.81 No.12 | 753-774 | Chairpersons:H. TOMIOKA and K. NAMBA | Development of Antituberculous Drugs:Current Status and Future Prospects |
| Drug targets | Vol.85 No.02 | 113-123 | Haruaki TOMIOKA and Atsuhiko TADA | CAN WE HAVE ADEQUATE
CHEMOTHERAPY REGIMENS FOR TUBERCULOSIS IN THE FUTURE ? |
| Drug targets | Vol.85 No.11 | 809-813 | Haruaki TOMIOKA | PROSPECTS FOR THE DEVELOPMENT OF NEW ANTITUBERCULOUS DRUGS PUTTING OUR HOPES ON NEW DRUG TARGETS |
| Drug therapy in combination with surgery | Vol.86 No.08 | 751-755 | Yoshiaki TAO et al. | CLINICAL INVESTIGATION OF MULTIDRUG-RESISTANT TUBERCULOSIS ─ Investigation of Inpatients in the Kyushu Region between 2004 and 2009 ─ |
| Drug treatment | Vol.75 No.07 | 471-476 | Kazuhiro SATO et al. | A Study on the Effect of Combined Chemotherapy on Mycobacterium avium Complex Pulmonary Disease |
| Drug-induced | Vol.78 No.07 | 491-496 | Tetsuya ONODA et al. | Rifampicin-Induced Severe Thrombocytopenia in a Patient with Miliary Tuberculosis |
| Drug-induced hepatitis | Vol.75 No.11 | 665-673 | Masako WADA | The Effectiveness of Pyrazinamide-Containing Six-Month Short Course Chemotherapy |
| Drug-induced hepatitis | Vol.78 No.01 | 15-19 | Naoki MIYAZAWA et al. | Effect of Glycyrrhizin on Anti-Tuberculosis Drug-Induced Hepatitis |
| Drug-induced hepatitis | Vol.78 No.04 | 339-346 | Naohiro NAGAYAMA et al. | Secular Increase in the Incidence Rate of Drug-Induced Hepatitis Due to Anti-Tuberculosis Chemotherapy Including Isoniazid and Rifampicin |
| Drug-induced hepatotoxicity | Vol.86 No.02 | 87-99 | Chairpersons: K. TSUYUGUCHI and M. WADA |
MANAGEMENT OF ADVERSE EFFECTS WITH ANTITUBERCULOSIS CHEMOTHERAPY |
| Drug-induced hepatotoxicity (DIH) | Vol.83 No.01 | 13-19 | Yugo KANEKO et al. | Drug-Induced Hepatotoxicity Caused by Anti-Tuberculosis Drugs in Tuberculosis Patients Complicated with Chronic Hepatitis |
| Drug-induced interstitial nephritis | Vol.84 No.08 | 591-595 | Hiroyuki AMANO et al. | A Case of Sternoclavicular Joint Tuberculosis with Renal Failure due to Rifampicin |
| Drug-induced interstitial nephritis | Vol.84 No.08 | 591-595 | Hiroyuki AMANO et al. | A Case of Sternoclavicular Joint Tuberculosis with Renal Failure due to Rifampicin |
| Drug-induced interstitial pneumonia | Vol.78 No.05 | 401-406 | Hidekazu MATSUSHIMA et al. | A Case of Isoniazid Sodium Methanesulfonate Induced Interstitial Pneumonia |
| Drug-induced pneumonitis | Vol.86 No.04 | 473-476 | Chihiro NISHIO et. al. | PNEUMONITIS INDUCED BY RIFAMPICIN |
| Drug-resistant tuberculosis | Vol.76 No.04 | 379-383 | Eriko SHIGETO et al. | A Case of Drug-Resistant Pulmonary Tuberculosis Treated Successfully Following Disappearance of Rifampicin Resistance after 17 Years' Chemotherapy |
| Drug-resistant tuberculosis | Vol.78 No.02 | 83-87 | Makoto YONEMARU et al. | Trends in Drug-Resistant Tuberculosis in National Higashisaitama Hospital, 1994-2001 |
| Drug-resistant tuberculosis | Vol.85 No.10 | 757-760 | Eriko SHIGETO | THE CURRENT STATUS OF FLUOROQUINOLONES AND OTHER OFF-LABEL DRUG USE FOR TUBERCULOSIS IN JAPAN |
| Drug-susceptibility test | Vol.81 No.07 | 475-479 | Shiomi YOSHIDA et al. | Detection of rpoB Mutations in Rifampicin-Resistant Mycobacterium kansasii |
| Due process of law | Vol.83 No.02 | 111-114 | Shigeru TAKAHASHI | Human Rights of Patients and tuberculosis Prevention |
| Duration of chemotherapy | Vol.88 No.04 | 417-422 | Toru MORI et al. | IMPACT OF INTRODUCING RIFAMPICIN ON THE TREATMENT OF TUBERCULOSIS DURING THE 1970'S IN JAPAN |
| Duration of hospitalization | Vol.87 No.04 | 351-355 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ─Series 9. Treatment of TB (2)─ |
| Duration of hospitalization | Vol.88 No.04 | 439-443 | Tuberculosis Surveillance Center (TSC), RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2010 ─ (9) Treatment of Tuberculosis ─ 2 ─ |
| Duration of treatment | Vol.87 No.04 | 351-355 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 ─Series 9. Treatment of TB (2)─ |
| Duration of treatment | Vol.88 No.04 | 439-443 | Tuberculosis Surveillance Center (TSC), RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2010 ─ (9) Treatment of Tuberculosis ─ 2 ─ |